Home > News By Company > WMR
Interspinous Process Decompression Devices Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026
Interspinous Process Market Report 2018-2026 has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.
(EMAILWIRE.COM, October 02, 2018 ) Interspinous process decompression (IPD) is a minimally invasive procedure that is used by spine surgeons to relieve symptoms of lumbar spinal stenosis. IPD is an example of the advancements in the field of minimally invasive spine surgery and is sometimes performed as an alternative to decompression spine surgery such as a laminectomy. This procedure is carried out by implanting a device called as spacer or interspinous spacer. This implant is inserted between the spinous processes. Spinous processes are the thin, bony projections on the back of the spine, which can be felt when we run our hand over the spine.
Request a Sample Copy:https://www.worldwidemarketreports.com/sample/167571
Increasing aging populations worldwide is one of the major factors that is driving growth of interspinous process decompression devices market. Spinal fusion is currently considered as the best for degenerative spine treatment, which accomplishes both deformity correction and stabilization.
Nowadays, people prefer nonfusion technologies, owing to sequela associated with a successful fusion procedure and this is expected to be a factor that will restrain growth of interspinous process decompression devices market over the forecast period.
Key Developments in Interspinous Process Decompression Devices Market
Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the interspinous process decompression devices market. On April 17, 2018, Medtronic expanded its focus on Interventional Oncology with the U.S. launch of OptiSphere (TM) Embolization Spheres. On April 10, 2018, Medtronic announced the CE Mark and European launch of the Visualase (TM) MRI-Guided Laser Ablation System.
In 2017, Global Medical, a leading musculoskeletal solutions company announced that Excelsius GPS™ was cleared by the U.S. Food and Drug Administration (FDA). Furthermore, Paradigm Spine, LLC, a leader in providing motion preservation solutions for the treatment of lumbar spinal stenosis announced about its publication of the ESCADA 2-year trial results (European Study of coflex And Decompression Alone) in January 2018. In 2017, Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis announced completion of US$ 40 Mn financing round.
Inquire before Buying: https://www.worldwidemarketreports.com/quiry/167571
Some of the key players operating in the interspinous process decompression devices market include Globus Medical, Medtronic, Paradigm Spine, and Vertiflex.
Request a Sample Copy:https://www.worldwidemarketreports.com/sample/167571
Increasing aging populations worldwide is one of the major factors that is driving growth of interspinous process decompression devices market. Spinal fusion is currently considered as the best for degenerative spine treatment, which accomplishes both deformity correction and stabilization.
Nowadays, people prefer nonfusion technologies, owing to sequela associated with a successful fusion procedure and this is expected to be a factor that will restrain growth of interspinous process decompression devices market over the forecast period.
Key Developments in Interspinous Process Decompression Devices Market
Key players are adopting various strategies such as mergers, acquisitions, new product launches, expansions, collaborations, partnerships, approvals, and joint ventures to retain its position in the interspinous process decompression devices market. On April 17, 2018, Medtronic expanded its focus on Interventional Oncology with the U.S. launch of OptiSphere (TM) Embolization Spheres. On April 10, 2018, Medtronic announced the CE Mark and European launch of the Visualase (TM) MRI-Guided Laser Ablation System.
In 2017, Global Medical, a leading musculoskeletal solutions company announced that Excelsius GPS™ was cleared by the U.S. Food and Drug Administration (FDA). Furthermore, Paradigm Spine, LLC, a leader in providing motion preservation solutions for the treatment of lumbar spinal stenosis announced about its publication of the ESCADA 2-year trial results (European Study of coflex And Decompression Alone) in January 2018. In 2017, Vertiflex, Inc., a leading innovator of advanced, minimally invasive interventions for spinal stenosis announced completion of US$ 40 Mn financing round.
Inquire before Buying: https://www.worldwidemarketreports.com/quiry/167571
Some of the key players operating in the interspinous process decompression devices market include Globus Medical, Medtronic, Paradigm Spine, and Vertiflex.
Contact Information:
WMR
Mr. Shah
Tel: 8087996871
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
WMR
Mr. Shah
Tel: 8087996871
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results